Diffúz nagy B-sejtes limfóma (DLBCL): nyitott vizsgálatok itt: Mexikó
4 trials · From ClinicalTrials.gov, checked 2026. nov. 10.. Ask the study team whether a trial fits you.
2/3. fázisToborozTrial-stage medicine
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
- Where
- Chihuahua City, Mexico City
- Age
- 18 év and over
- People
- 290 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT05139017EU 2022-502646-27-00Regiszter frissítve: 2026-11-03
3. fázisToborozTrial-stage medicine
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
- Where
- Mexico City, Monterrey, Morelia, Oaxaca City, Pachuca, Torreón
- Age
- 18 év and over
- People
- 1046 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06717347EU 2024-515566-13-00Regiszter frissítve: 2026-10-21
2. fázisToborozTrial-stage medicine
Low Dose Epcoritamab Plus GemOx in R/R DLBCL
- Where
- Monterrey
- Age
- 18 év to 65 év
- People
- 10
- Run by
- Hospital Universitario Dr. Jose E. Gonzalez
See details and how to joinNCT07451652Regiszter frissítve: 2026-04-01
No phaseToborozResearch participation
Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma
- Where
- Huixquilucan de Degollado, Mexico City
- Age
- 18 év and over
- People
- 700 worldwide
- Run by
- AbbVie
See details and how to joinNCT06830759Regiszter frissítve: 2026-02-17
Minden vizsgálat (Diffúz nagy B-sejtes limfóma (DLBCL)) és a térkép
Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.